Loading clinical trials...

RECRUITING

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Visual and Refractive Outcomes of the Clareon PanOptix Pro IOL in Patients With Prior Myopic Refractive Surgery

NCT06555289•Juliette Eye Institute Research Center

Summary

This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.

Eligibility

Age

45 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery.
•Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK.
•Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL.
•Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3
•Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement.

Exclusion Criteria

•Any ocular comorbidity that might hamper postoperative visual acuity:
•* Corneal abnormality including corneal dystrophy, irregularity, and degeneration.
•* Moderate or severe dry eyes that can't be relieved after treatment.
•* History of or current anterior and posterior inflammation of any etiology.
•* Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc.
•* Glaucoma of any kind.
•* Pregnancy or lactation.
•Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK).
•Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate)
•Apple Kappa/chord mu ≥ 0.6.
+3 more criteria

Locations (1)

Juliette Eye Institute Research Center

Albuquerque, New Mexico, United States

Key Dates

Start Date

October 23, 2024

Primary Completion Date

September 1, 2026

Completion Date

September 1, 2026

Last Updated

December 12, 2025

Enrollment

ESTIMATED participants

Conditions

Cataract

Interventions

Clareon PanOptix Pro IOL

DEVICE

Contacts

Zoe Baker, OD

CONTACT

505-355-2020 dr.baker@julietteeye.com

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

NCT06979752

Glaucoma, Open Angle, Pseudo-exfoliativeCataract

View study

RECRUITING

Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)

NCT07362043

Cataract Surgery

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Inclusion Criteria

Exclusion Criteria

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)

IC-8 Apthera IOL New Enrollment Post Approval Study

HUD Surgical Guidance for Toric Alignment

PRO-232 in Patients Subjected to Cataract Surgery

General Anesthesia on Blood Pressure and Intraocular Pressure in Geriatric Patients Undergoing Cataract Surgery